• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术用于治疗无腹水的肝性胸水

Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.

作者信息

Andrade R J, Martin-Palanca A, Fraile J M, Alcantara R, Carmona C, Medina M C, Muñoz V, Melgarejo F

机构信息

Department of Gastroenterology, University Hospital School of Medicine, Málaga, Spain.

出版信息

J Clin Gastroenterol. 1996 Jun;22(4):305-7. doi: 10.1097/00004836-199606000-00013.

DOI:10.1097/00004836-199606000-00013
PMID:8771428
Abstract

Hepatic hydrothorax in the absence of clinical ascites (HHAA) is a somewhat rare complication in decompensated cirrhosis. Patients with HHAA have a congenital defect in the tendinous portion of the diaphragm allowing rapid leakage of ascites into pleural cavity because of the cyclical negative intrathoracic pressure. Although several therapeutic approaches, including peritoneovenous shunt and chemical or surgical pleurodesis, have been attempted in these patients the results are largely unsatisfactory. A poor-risk surgical cirrhotic woman who was also considered not suitable for liver transplantation underwent transjugular intrahepatic portosystemic shunt (TIPS) for palliation of HHAA. After TIPS procedure hydrothorax completely resolved. TIPS can offer an attractive alternative to standard therapy in cirrhotic patients with HHAA.

摘要

无临床腹水的肝性胸水(HHAA)是失代偿期肝硬化中一种较为罕见的并发症。HHAA患者在膈肌腱部存在先天性缺陷,由于胸腔内压力周期性负压,使得腹水迅速漏入胸腔。尽管已对这些患者尝试了多种治疗方法,包括腹腔静脉分流术以及化学或手术性胸膜固定术,但结果大多不尽人意。一名手术风险高且被认为不适合肝移植的肝硬化女性患者,接受了经颈静脉肝内门体分流术(TIPS)以缓解HHAA。TIPS术后胸水完全消退。对于患有HHAA的肝硬化患者,TIPS可为标准治疗提供一种有吸引力的替代方案。

相似文献

1
Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.经颈静脉肝内门体分流术用于治疗无腹水的肝性胸水
J Clin Gastroenterol. 1996 Jun;22(4):305-7. doi: 10.1097/00004836-199606000-00013.
2
Transjugular intrahepatic portosystemic shunt in refractory hydrothorax - a contribution to an unexplored indication.经颈静脉肝内门体分流术治疗难治性胸腔积液——对一个未被探索适应症的贡献
Eur J Gastroenterol Hepatol. 2016 Jun;28(6):661-6. doi: 10.1097/MEG.0000000000000623.
3
Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.经颈静脉肝内门体分流术与难治性肝性胸腔积液患者的肝移植
Liver Transpl Surg. 1998 Sep;4(5):416-23. doi: 10.1002/lt.500040506.
4
[Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].[无腹水的胸腔积液:肝硬化门静脉高压的一种罕见并发症]
Clin Ter. 2005 Jul-Aug;156(4):179-81.
5
Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax.经颈静脉肝内门体分流术治疗复发性肝性胸水
Ann Thorac Surg. 2000 Feb;69(2):609-11. doi: 10.1016/s0003-4975(99)01351-x.
6
Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术治疗难治性肝性胸腔积液
J Gastroenterol. 1999 Feb;34(1):128-31. doi: 10.1007/s005350050228.
7
The outcome after transjugular intrahepatic portosystemic shunt (TIPS) for hepatic hydrothorax is closely related to liver dysfunction: a long-term study in 28 patients.经颈静脉肝内门体分流术(TIPS)治疗肝性胸水的疗效与肝功能障碍密切相关:28例患者的长期研究
Acta Gastroenterol Belg. 2007 Jan-Mar;70(1):6-10.
8
An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations.一种根据临床表现进行经颈静脉肝内门体分流术放置后管理的算法。
Dig Dis Sci. 2017 Feb;62(2):305-318. doi: 10.1007/s10620-016-4399-4. Epub 2017 Jan 5.
9
Hepatic hydrothorax does not increase the risk of death after transjugular intrahepatic portosystemic shunt in cirrhosis patients.肝性胸水并不会增加肝硬化患者经颈静脉肝内门体分流术后的死亡风险。
Eur Radiol. 2023 May;33(5):3407-3415. doi: 10.1007/s00330-022-09357-3. Epub 2022 Dec 28.
10
[Hepatic hydrothorax: presentation of 3 cases with different therapeutic approaches].[肝性胸水:3例不同治疗方法的病例报告]
Rev Gastroenterol Peru. 2019 Jan-Mar;39(1):64-69.

引用本文的文献

1
Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis.经颈静脉肝内门体分流术治疗内科难治性肝性胸水:一项系统评价和累积荟萃分析
World J Hepatol. 2015 Jul 8;7(13):1797-806. doi: 10.4254/wjh.v7.i13.1797.
2
Outcomes of transjugular intrahepatic portosystemic shunts for ascites.经颈静脉肝内门体分流术治疗腹水的疗效
Semin Intervent Radiol. 2014 Sep;31(3):248-51. doi: 10.1055/s-0034-1382792.
3
Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis.
化学性胸膜固定术用于失代偿期肝硬化患者难治性肝性胸水的治疗
Korean J Hepatol. 2011 Dec;17(4):292-8. doi: 10.3350/kjhep.2011.17.4.292.
4
Outcomes of patients with chest tube insertion for hepatic hydrothorax.胸腔引流管置入治疗肝性胸水患者的结局。
Hepatol Int. 2009 Dec;3(4):582-6. doi: 10.1007/s12072-009-9136-z. Epub 2009 Aug 11.
5
The use and misuse of transjugular intrahepatic portasystemic shunts.经颈静脉肝内门体分流术的应用与误用
Curr Gastroenterol Rep. 2000 Feb;2(1):61-71. doi: 10.1007/s11894-000-0053-5.
6
A successful surgical repair of the hepatic hydrothorax using pneumoperitoneum: report of a case.使用气腹法成功手术修复肝性胸水:病例报告
Surg Today. 1999;29(8):795-8. doi: 10.1007/BF02482331.
7
Current status of transjugular intrahepatic portosystemic shunts.经颈静脉肝内门体分流术的现状
Postgrad Med J. 1998 Dec;74(878):716-20. doi: 10.1136/pgmj.74.878.716.